Cardiovascular risk assessment of the diabetic patient undergoing major noncardiac surgery

Area of Science:

• Cardiology
• Diabetology
• Anesthesiology

Background:

• Noncardiac surgery increases cardiovascular morbidity and mortality risk.
• Diabetes is a significant, growing risk factor for cardiovascular events, often presenting with silent ischemia.
• Accurate preoperative risk stratification is crucial for managing perioperative cardiac events.

Purpose of the Study:

• To highlight the importance of risk stratification for perioperative cardiac events in patients undergoing noncardiac surgery.
• To emphasize the increased risk in diabetic patients and the utility of non-invasive stress testing.
• To discuss strategies for reducing perioperative cardiac events.

Main Methods:

• Review of current literature on perioperative cardiac risk assessment.
• Discussion of exercise stress testing limitations in patients with comorbidities.
• Evaluation of pharmacologic stress testing (dobutamine stress echocardiography, dipyridamole myocardial perfusion scintigraphy) for limited exercise capacity patients.
• Consideration of non-invasive stress testing for asymptomatic coronary artery disease detection, particularly in diabetics.

Main Results:

• Diabetic patients have a higher prevalence of silent ischemia.
• Pharmacologic stress testing is a viable alternative for patients with limited exercise capacity.
• Non-invasive stress testing can identify asymptomatic coronary artery disease.
• Pharmacological treatment (beta-blockers, statins, aspirin) is associated with improved postoperative outcomes.

Conclusions:

• Non-invasive stress testing is recommended for diabetic patients undergoing noncardiac surgery to detect silent ischemia.
• Pharmacological interventions may improve postoperative outcomes in high-risk patients.
• Further research is needed on the controversial role of prophylactic coronary revascularization.